Abstract

LACRUZ, Julio et al. Tratamiento con braquiterapia intersticial de alta tasa de dosis en cáncer de mama precoz. Rev. venez. oncol. [online]. 2009, vol.21, n.4, pp.203-211. ISSN 0798-0582.

The breast cancer represents a public health problem. The breast cancer is entities which increase his incidence in the world. These problem do to a creation of new surgery, chemical and radiant therapeutically modes. In these work we mention the high dose brachytherapy tease doses realized in the University Merida Hospital in the integral service of oncology. We evaluated 148 patients with breast cancer disease in all the stage since February 2007 to May 30 of 2008. We selected a148 patients classified stage I-IIA NO MO, and analyzed the patients with have inclusion therapeutically criterions. In 19 (12.8 %) patients were underwent to interstitial brachytherapy hyperfraccion with and interval to 6 hours (800 cGy/day) in 4 sessions (400 cGy for fraction). Total doses applied was 3 200 cGy. With a control range between 18 month and 2 month, and average of 10 month without any evidence of loco regional distress.

Keywords : Cancer; breast; early; brachytherapy; implant; high dose; Ir 192.